October 12, 2021, Vol 326, No. 14, Pages 1353-1452
Surveillance for Adverse Events After COVID-19 mRNA Vaccination
Nicola P. Klein, MD, PhD; Ned Lewis, MPH; Kristin Goddard, MPH; et al.
free access has active quiz
JAMA. 2021;326(14):1390-1399. doi:10.1001/jama.2021.15072
This study reports an interim analysis of safety surveillance data of 23 serious outcomes following vaccination with 1 of the mRNA COVID-19 vaccines based on comprehensive health records from a large US population.